Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1469-1474

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Merriam, C Vreni ^a  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LINEZOLID; MACROLIDE; TEICOPLANIN; VANCOMYCIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BITE WOUND; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE; WOUND INFECTION;

EID: 0033067070     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1469     Document Type: Article

References (25)

1. Alexander, C. J., D. M. Citron, S. H. Gerardo, M. C. Claros, D. Talan, and E. J. C. Goldstein. 1997. Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J. Clin. Microbiol. 35:406-411.
2. Anonymous. 30 May 1997. Dog bites have increased 37%, p. A-3. The Outlook, Santa Monica, Calif.
3. Brook, I. 1987. Microbiology of human and animal bite wounds in children. Pediatr. Infect. Dis. J. 6:29-32.
4. Citron, D. M., M. C. Claros, S. H. Gerardo, F. Abrahamian, D. A. Talan, and E. J. C. Goldstein. 1996. Frequency of Porphyromonas species isolated from infected dog and cat bite wounds in humans and their characterization by biochemical tests and AP-PCR fingerprinting. Clin. Infect. Dis. 23(Suppl. 1): 78-82.
5. Dresser, L. D., and M. J. Rybak. 1998. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 18:456-462.
6. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
7. Goldstein, E. J. C. 1991. Bite wounds and infection. Clin. Infect. Dis. 14: 633-640.
8. Goldstein, E. J. C., D. M. Citron, B. Wield, U. Blachman, V. L. Sutter, T. A. Miller, and S. M. Finegold. 1978. Bacteriology of human and animal bite wounds. J. Clin. Microbiol. 8:667-672.
9. Goldstein, E. J. C., D. M. Citron, S. H. Gerardo, M. Hudspeth, and C. V. Merriam. 1998. Activities of HMR 3004 (RU-64004) and HMR 3647 (RU-66647) compared to those of erythromycin, azithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal pathogens isolated from skin and soft tissue infections in humans. Antimicrob. Agents Chemother. 42:1127-1132.
10. Goldstein, E. J. C., D. M. Citron, M. Hudspeth, S. H. Gerardo, and C. V. Merriam. 1998. Trovafloxacin compared to levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite wound pathogens. J. Antimicrob. Chemother. 41:391-396.
11. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg.
12. Holst, E., J. Rollof, L. Larsson, and J. P. Nielsen. 1992. Characterization and distribution of Pasteurella species recovered from infected humans. J. Clin. Microbiol. 30:2984-2987.
13. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
14. Jorgensen, J. H., M. L. McElmeel, and C. W. Trippy. 1997. In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species. Antimicrob. Agents Chemother. 41:465-467.
15. Levin, J. M., and D. A. Talan. 1990. Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat bite victim. Ann. Emerg. Med. 19:1458-1461.
16. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
17. Mutters, R., P. Ihm, S. Pohl, W. Frederiksen, and W. Mannheim. 1985. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis, and Pasteurella langaa. Int. J. Syst. Bacteriol. 35:309-322.
18. National Committee for Clinical Laboratory Standards. 1998. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 4th ed. Approved standard. NCCLS publication no. M11-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. National Committee for Clinical Laboratory Standards. 1998. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Orton, D. W. 1984. Pasteurella multocida: bilateral septic knee joint prosthesis from a distant cat bite. Ann. Emerg. Med. 13:1065-1067.
21. Sachs, J. J., M. Kresnow, and B. Houston. 1996. Dog bites: how big a problem? Injury Prev. 2:52-54.
22. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
23. Talan, D. A., D. M. Citron, F. A. Abrahamian, G. J. Moran, E. J. C. Goldstein, and the Emergency Medicine Animal Bite Infection Study Group. 1999. The bacteriology and management of dog and cat bite wound infections presenting to emergency departments. N. Engl. J. Med. 340:85-92.
24. Yagi, B. H., and G. E. Zurenko. 1997. In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteria. Anaerobe 3:301-306.
25. Zurenko, G. E., B. H. Yagi, R. A. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.